Healthcare Stocks Lose Defensive Edge Explore why healthcare stocks are losing their defensive appeal amid regulatory, political, clinical, and competitive dynamics. Discover insights here.
Paramount-Skydance Merger Faces FCC Scrutiny Paramount and Skydance are tackling criticisms and regulatory concerns as their merger awaits FCC approval. Key updates on this high-stakes merger.
SouthState's Acquisition Boosts Assets to $65 Billion SouthState Bank's recent acquisition elevates its assets to $65 billion, crossing the $50 billion mark, which entails enhanced regulatory requirements.
Nvidia Acquires Run:ai in $700 Million Deal Nvidia finalizes its $700 million acquisition of Run:ai amidst regulatory challenges, marking a significant move in the AI technology landscape.
Case Challenges NLRB's Authority and ALJ Constitutionality Explore the significant case questioning the NLRB's authority and the constitutionality of its administrative law judges.
Amedisys Shares Surge as Merger Deadline with UnitedHealth Extended Amedisys (AMED) shares rise after extending deadline for $3.3 billion merger with UnitedHealth Group (UNH), despite DOJ opposition. Learn more about this healthcare M&A deal.
UnitedHealth and Amedisys Extend $3.3 Billion Merger Deadline UnitedHealth Group and Amedisys have postponed the completion of their $3.3 billion merger, focusing on regulatory approvals in the healthcare industry.
President Biden's Upcoming Decision on Trade Policy President Joe Biden has 15 days to decide on a pivotal trade policy, impacting regulatory measures. Stay updated on this presidential decision.
Microsoft's Steady Growth Amid Regulatory Hurdles Discover how Microsoft maintains consistency despite regulatory challenges, with promising growth in the commercial sector.
FERC Rejection: AEP and Exelon Oppose Utility Deal FERC rejects deal opposed by American Electric Power and Exelon, a significant regulatory decision impacting the utility sector.